Add Yahoo as a preferred source to see more of our stories on Google. CystoSmart aims to help clinicians improve diagnostic accuracy during cystoscopy procedures. Credit: SOMKID THONGDEE / ...

SINGAPORE and LONDON and NEW YORK, Jan. 04, 2026 (GLOBE NEWSWIRE) -- Intelligent Scopes Corp (“ISC”), specializing in state-of-the-art image enhancement and precision AI software solutions for urology ...

While the creation of this new entity marks a big step toward avoiding a U.S. ban, as well as easing trade and tech-related tensions between Washington and Beijing, there is still uncertainty ...

You chose selected. Each dot here represents a single video about selected. While you’re on the app, TikTok tracks how you interact with videos. It monitors your watch time, the videos you like, the ...

I treat patients in a hospital. You’re a doctor who works for an insurance company. Are we really peers? Tessa Adzemovic is a physician at Brigham and Women’s Hospital. My phone rings and an ...

Personalized algorithms may quietly sabotage how people learn, nudging them into narrow tunnels of information even when they start with zero prior knowledge. In the study, participants using ...

2026 will be a major transition year for Medicare Advantage, with several significant changes to the program taking effect. These include the first round of government-negotiated drug prices, ongoing ...

Editor's Note: This is an excerpt from WBUR's weekly health newsletter, CommonHealth. If you like what you read and want it in your inbox, sign up here. Bladder cancer hits men especially hard. The ...

An experimental treatment method has shown promise in fighting a hard-to-treat form of bladder cancer known as BCG-unresponsive high-risk non-muscle-invasive bladder cancer (NMIBC). BCG (Bacillus ...

We’re racing towards a future in which devices will be able to read our thoughts. You see signs of it everywhere, from brain-computer interfaces to algorithms that detect emotions from facial scans.

An innovative new treatment option for bladder cancer, recently approved by the U.S. Food and Drug Administration, has been performed for the first time in Maryland. Dr. Heather Chalfin, a urologic ...

Results presented by AstraZeneca from its phase 3 trial of Imfinzi in patients with high-risk, non-muscle invasive bladder cancer (NMIBC) suggest the PD-L1 inhibitor measures up to Pfizer’s PD-1 ...